June 23, 2020 | 6:14 AM
A year in, first patient to get gene-editing for sickle cell disease is thriving
"It's the change I've been waiting on my whole life."
This study is not aimed at changing DNA within a person’s body. Instead it seeks to remove, alter and give back to the patient cells that are super-powered to fight their cancer — a form of immunotherapy.
The days of journalism’s one-way street of simply producing stories for the public have long been over. Now, it’s time to find better ways to interact with you and ensure we meet your high standards of what a credible media organization should be.